A detailed history of Simon Quick Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Simon Quick Advisors, LLC holds 6,354 shares of AZN stock, worth $415,233. This represents 0.03% of its overall portfolio holdings.

Number of Shares
6,354
Previous 6,162 3.12%
Holding current value
$415,233
Previous $480,000 3.13%
% of portfolio
0.03%
Previous 0.03%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$76.67 - $87.62 $14,720 - $16,823
192 Added 3.12%
6,354 $495,000
Q2 2024

Aug 02, 2024

BUY
$66.81 - $80.83 $104,223 - $126,094
1,560 Added 33.9%
6,162 $480,000
Q1 2024

Apr 19, 2024

BUY
$61.03 - $69.57 $17,454 - $19,897
286 Added 6.63%
4,602 $311,000
Q4 2023

Jan 16, 2024

SELL
$61.89 - $69.28 $2,537 - $2,840
-41 Reduced 0.94%
4,316 $290,000
Q3 2023

Oct 24, 2023

SELL
$64.85 - $71.7 $32,230 - $35,634
-497 Reduced 10.24%
4,357 $295,000
Q2 2023

Aug 01, 2023

BUY
$69.91 - $75.81 $52,991 - $57,463
758 Added 18.51%
4,854 $347,000
Q1 2023

May 15, 2023

BUY
$63.15 - $71.6 $43,699 - $49,547
692 Added 20.33%
4,096 $284,000
Q4 2022

Jan 30, 2023

BUY
$54.21 - $70.44 $184,530 - $239,777
3,404 New
3,404 $230,000
Q2 2021

Jul 21, 2021

SELL
$48.42 - $60.18 $4,938 - $6,138
-102 Closed
0 $0
Q1 2021

May 06, 2021

BUY
$47.16 - $54.44 $94 - $108
2 Added 2.0%
102 $5,000
Q4 2020

Jan 27, 2021

SELL
$48.52 - $58.02 $21,445 - $25,644
-442 Reduced 81.55%
100 $5,000
Q3 2020

Oct 26, 2020

BUY
$53.07 - $61.1 $28,763 - $33,116
542 New
542 $30,000
Q1 2020

Apr 09, 2020

SELL
$37.79 - $51.33 $36,618 - $49,738
-969 Closed
0 $0
Q4 2019

Jan 06, 2020

BUY
$42.46 - $50.46 $38,596 - $45,868
909 Added 1515.0%
969 $48,000
Q2 2019

Aug 05, 2019

BUY
$37.28 - $41.68 $2,236 - $2,500
60 New
60 $0
Q1 2018

May 07, 2018

SELL
$32.97 - $36.63 $4,945 - $5,494
-150 Closed
0 $0
Q4 2017

Feb 13, 2018

BUY
$32.09 - $34.78 $4,813 - $5,217
150
150 $5,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $203B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Simon Quick Advisors, LLC Portfolio

Follow Simon Quick Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simon Quick Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simon Quick Advisors, LLC with notifications on news.